SYNCHRONIZE: real-world retrospective safety analysis in chronic migraine patients treated with OnabotulinumtoxinA for ≥1 indication
Year: 2024
Type: conference-paper
Study design: Observational Study
Authors: Blumenfeld Andrew, Forde Grace, Ifantides Kim Becker, Singh Ritu, Sommer Katherine, Battucci Simona, Crocker Alicia, Rhyne Christopher
Institutions: AbbVie (United Kingdom), Diamond Headache Clinic
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404183492